Convenient One Step 300 ng/ml Methadone Panel Powder Drug Abuse Test Kit Wiht High Sensitivity
The Methadone Rapid Test Panel is a rapid chromatographic immunoassay for the qualitative detection of Methadone at a cut-off 300ng/ml.
This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated.
Methadone is a narcotic analgesic prescribed for the management of moderate to severe pain and for the treatment of opiate dependence (heroin, Vicodin, Percocet, morphine). The pharmacology of oral methadone is very different from IV methadone. Oral methadone is partially stored in the liver for later use. IV methadone acts more like heroin. In most states you must go to a pain clinic or a methadone maintenance clinic to be prescribed methadone.
Methadone is a long acting pain reliever producing effects that last from twelve to forty-eight hours. Ideally, methadone frees the client from the pressures of obtaining illegal heroin, from the dangers of injection, and from the emotional roller coaster that most opiates produce. Methadone, if taken for long periods and at large doses, can lead to a very long withdrawal period. The withdrawals from methadone are more prolonged and troublesome than those provoked by heroin cessation, yet the substitution and phased removal of methadone is an acceptable method of detoxification for patients and therapists.
The Methadone contained within the MTD Rapid Test Panel yields a positive result when the MTD concentration exceeds 300ng/ml.
How to use?
Test device (in closed pouches), samples, and controls should be brought to room temperature (15-30°C) prior to testing. Do not open pouches until ready to perform the assay.
Remove the test device from its protective pouch and label the device with patient’s identification or control label.
1. Wipe with the panel over the surface in which the drugs are expected
2. Take off the cap of supplied tube;
3. Fill all buffers from the supplied tube of buffer into the protection cover.
4. Insert the Multi Test slowly and carefully into the protection cover with buffer
5. Wait for lines to appear on the membrane and read the results after 5 minutes and do not interpret the result after 10 minutes.
1. Open the tube and put the solid in to the buffer.
2. Close the tube with dropper and cap. Shake it a short time. Wait for 30 sec.
3. Take off the cap of supplied tube;
4. Fill all buffers with dissolved substances into the protection cover.
5. Insert the Multi Test slowly and carefully into the protection cover with buffer.
6. Wait for lines to appear on the membrane and read the results after 5 minutes and do not interpret the result after 10 minutes.
INTERPRETATION OF RESULTS
(Please refer to the illustration above)
NEGATIVE:* A colored line appears in the Control region (C) and colored lines appear in the Test region (T). This negative result means that the concentrations in the sample are below the designated cut-off levels for a particular drug tested.
*NOTE: The shade of the colored lines(s) in the Test region (T) may vary. The result should be considered negative whenever there is even a faint line.
POSITIVE: A colored line appears in the Control region (C) and NO line appears in the Test region (T). The positive result means that the drug concentration in the sample is greater than the designated cut-off for a specific drug.
INVALID: No line appears in the Control region (C). Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for Control line failure. Read the directions again and repeat the test with a new test card. If the result is still invalid, contact your manufacturer.